Women carrying BRCA1 mutations face a 39%-44% lifetime risk, while BRCA2 mutation carriers have an 11%-17% lifetime risk of developing ovarian cancer (American Cancer Society). This evidence concerns the gene BRCA1 and ovarian carcinoma.